Advanced Search:
Equity Index

DIM.PA - SARTORIUS STED BIO

€264.30  2 (0.76%)

Updated: 12:02 May 5, 2024 EST

Next Session's AI Forecast

77.8%

Avg. Accuracy (AI)

€263.63

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

€280.58

SARTORIUS STED BIO's Position Within the Medical Instruments & Supplies Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

SARTORIUS STED BIO - HISTORICAL DATA 6M

  • Last price

    €264.30

  • Daily change

    €2

  • Previous Close

    €262.3

  • Last Updated

    12:02 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.19 -1.3 -0.36 0.05 -0.03

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.31 2.85 2 1.85 1.97

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 20.9% 13.46% 9.46%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
206.2 0.15% 205.89 -12.8% 236.12 3.25% 228.68

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.75 76.19 0.37 42.86

SARTORIUS STED BIO Technical Analysis News

SARTORIUS STED BIO

Zone Industrielle Les Paluds
Avenue de Jouques – CS 91051 Cedex
Aubagne 13781
France
33 4 42 84 56 00
https://www.sartorius.com

Sectors: Healthcare
Industry: Medical Instruments & Supplies
F. Time Employees: 10493
Description

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Corporate Governance

Sartorius Stedim Biotech S.A.’s ISS Governance QualityScore as of May 1, 2024 is 6. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 8; Compensation: 8.

SARTORIUS STED BIO'S HOLDERS RANK

List of holders with stock participation in SARTORIUS STED BIO.

Holder Rank Holder Shares Date Reported % Out Value